Company Name: |
Bide Pharmatech Ltd.
|
Tel: |
400-164-7117 13681763483 |
Email: |
product02@bidepharm.com |
Products Intro: |
Product Name:2-Hydroxy-6-(2-(naphthalen-2-yl)ethyl)benzoic acid CAS:365542-77-4 Purity:99% Package:5mg;10mg;25mg;50mg;100mg Remarks:BD01156002
|
Company Name: |
Shanghai shuji biotechnology co., ltd.
|
Tel: |
021-021-62200788 15000569291 |
Email: |
zhanlingrui@163.com |
Products Intro: |
Product Name:2-Hydroxy-6-(2-naphthalen-2-yl-ethyl)-benzoic acid CAS:365542-77-4 Purity:95+ Package:100mg/RMB 3000
|
2-Hydroxy-6-(2-naphthalen-2-yl-ethyl)-benzoic acid manufacturers
- SM4
-
- $93.00 / 1mg
-
2024-11-19
- CAS:365542-77-4
- Min. Order:
- Purity: 98.1%
- Supply Ability: 10g
|
| 2-Hydroxy-6-(2-naphthalen-2-yl-ethyl)-benzoic acid Basic information |
| 2-Hydroxy-6-(2-naphthalen-2-yl-ethyl)-benzoic acid Chemical Properties |
storage temp. | 2-8°C | solubility | DMSO: 2mg/mL, clear | form | Solid | color | Off-white to light brown |
| 2-Hydroxy-6-(2-naphthalen-2-yl-ethyl)-benzoic acid Usage And Synthesis |
Description | Sm4 is a novel SOX18 blocker, suppressing genes downstream of the gene for Sox18 and interferring with vascular development, showing anti-cancer and anti-metastatic effects. | Uses | Sm4 is a SOX18 inhibitor. Sm4 shows SOX18-DNA binding inhibitory activity. Sm4 selectively affects SOX18 transcriptional output in vitro. Sm4 blocks SoxF transcriptional activity in vivo. Sm4 can be used for cancer metastasis and vascular cancers research[1]. | References | [1] Mathias FRANCOIS. Inhibitors of sox18 protein activity for treating angiogenesis- and/or lymphangiogenesis-related diseases. Patent, WO2018112545A1. |
| 2-Hydroxy-6-(2-naphthalen-2-yl-ethyl)-benzoic acid Preparation Products And Raw materials |
|